Tracking dendritic cells: use of an in situ method to label all blood leukocytes

Bill Ristevski1, Alan J Young, Lisbet Dudler

  • 1Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 Kings' College Circle, Toronto, Ontario M5S 1A8, Canada.

International Immunology
|February 13, 2003
PubMed

Insights

We developed a novel in situ cell tracking method to monitor dendritic cell (DC) precursors. This technique achieves high labeling efficiency (>98%) for tracking cells from blood to lymphoid tissues.

Area of Science:

  • Immunology
  • Cell Biology
  • Biotechnology

Background:

  • Tracking immune cell populations, particularly dendritic cell (DC) precursors, is crucial for understanding immune responses.
  • Existing in vitro labeling methods have limitations that can affect cell function and migratory capacity.

Purpose of the Study:

  • To develop and validate a novel in situ procedure for high-efficiency labeling and tracking of blood leukocytes, specifically dendritic cell (DC) precursors.
  • To enable direct tracking of DC precursors from blood into lymphoid tissues.

Main Methods:

  • An in situ procedure was established for labeling blood leukocytes.
  • The labeling efficiency was assessed using a labeling index, aiming for >98%.

Main Results:

  • The in situ procedure achieved a labeling index exceeding 98% for blood leukocytes.
  • This high labeling efficiency allows for direct tracking of dendritic cell (DC) precursors migration.
  • Dendritic cells and lymphocytes exhibit comparable migratory capabilities from blood to afferent lymph.

Conclusions:

  • The described in situ method provides a robust approach for tracking dendritic cell (DC) precursors and other rare cell populations.
  • This technique circumvents the limitations of in vitro labeling, offering broader applications in normal and pathological states.

Related Concept Videos